Page last updated: 2024-10-23

azathioprine and Cutis Laxa

azathioprine has been researched along with Cutis Laxa in 1 studies

Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.

Cutis Laxa: A group of connective tissue diseases in which skin hangs in loose pendulous folds. It is believed to be associated with decreased elastic tissue formation as well as an abnormality in elastin formation. Cutis laxa is usually a genetic disease, but acquired cases have been reported. (From Dorland, 27th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Convit, J1
Kerdel, F1
Goihman, M1
Rondon, AJ1
Soto, JM1

Other Studies

1 other study available for azathioprine and Cutis Laxa

ArticleYear
Progressive, atrophying, chronic granulomatous dermohypodermitis. Autoimmune disease?
    Archives of dermatology, 1973, Volume: 107, Issue:2

    Topics: Adult; Atrophy; Autoimmune Diseases; Axilla; Azathioprine; BCG Vaccine; Chronic Disease; Cutis Laxa;

1973